- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
Fieldview Capital Management Invests $5.34M in Boston Scientific
The hedge fund purchased 54,715 shares of the medical equipment provider's stock.
Published on Mar. 9, 2026
Got story updates? Submit your updates here. ›
Fieldview Capital Management LLC purchased a new stake in shares of Boston Scientific Corporation (NYSE:BSX) in the 3rd quarter, according to a recent filing with the Securities and Exchange Commission. The fund purchased 54,715 shares of the medical equipment provider's stock, valued at approximately $5,342,000.
Why it matters
This investment highlights the continued interest from institutional investors in Boston Scientific, a major medical device company. Fieldview Capital Management's stake in Boston Scientific represents approximately 0.9% of the firm's total holdings.
The details
According to the filing, Fieldview Capital Management purchased 54,715 shares of Boston Scientific stock in the third quarter of the year. The shares were valued at around $5.34 million, making Boston Scientific the 11th largest position in the fund's portfolio.
- Fieldview Capital Management purchased the Boston Scientific shares in the 3rd quarter of the year.
The players
Fieldview Capital Management LLC
A hedge fund that purchased a new stake in shares of Boston Scientific Corporation.
Boston Scientific Corporation
A global medical device company that develops, manufactures and markets a broad portfolio of products used in less-invasive medical procedures.
The takeaway
This investment by Fieldview Capital Management underscores the continued investor confidence in Boston Scientific's medical technology and growth prospects, despite broader market volatility.


